Alkermes appoints Mark Stejbach CCO
This article was originally published in Scrip
Biopharmaceutical company Alkermes has appointed Mark Stejbach its first chief commercial officer. Mr Stejbach most recently served as chief commercial officer at Tengion, and was previously vice-president of managed care marketing at Merck & Co. He has 25 years' experience in sales and marketing in the biotech and pharmaceutical industries.